Perspectives on the 2018 HHS Drug Pricing Guidance

May 10, 2018 @ 1:00 am

Share:

Next week, President Trump is scheduled to deliver a speech on drug pricing that will coincide with the release of a request for information (RFI) from the Department of Health and Human Services. This exclusive reporter briefing will feature a representative from the Administration, followed by a panel of industry leaders and stakeholders responding to new drug pricing guidance.

  • Kristin Bass, M.B.A., Senior Vice President, Policy and Federal Affairs, Pharmaceutical Care Management Association

  • Lori Reilly, J.D., Executive Vice President, Policy, Research, & Membership, PhRMA 

  • Justine Handelman, Senior Vice President, Office of Policy and Representation, Blue Cross Blue Shield Association

  • Rodney Whitlock, M.A., Ph.D., Consultant for the Campaign for Sustainable Rx Pricing and Vice President, Health Policy, ML Strategies 

  • Moderator: Mary Ella Payne, R.N., M.S.P.H., Acting President and Chief Executive Officer, Alliance for Health Policy

Thursday, May 10
9-10:30 a.m. (Refreshments and breakfast served at 8:30 a.m.) 

HOW TO PARTICIPATE

Remember that this briefing is on the record.

This event is only for credentialed members of the press.

You will need to check in with security to enter the building. Please bring your press credentials.

Registration will speed your access to the building, please register by 6 p.m. EST on May 9 to ensure availability of event materials.

CLICK HERE TO REGISTER

APCO Worldwide
Please use the entrance at 12th & E St.
1299 Pennsylvania Avenue, NW
Washington, D.C.

 

 

Details

  • Date: May 10, 2018
  • Time:
    1:00 am EDT
  • Event Category:
  • Event Tags: